EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+13.49%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.37B
AUM Growth
+$167M
(+14%)
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
120
Reduced
185
Closed
27
Top Buys
| 1 |
Microsoft
MSFT
|
$22.3M |
| 2 |
Pinduoduo
PDD
|
$13.5M |
| 3 |
NIO
NIO
|
$13.1M |
| 4 |
Marvell Technology
MRVL
|
$11.4M |
| 5 |
TSMC
TSM
|
$10.4M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$24.2M |
| 2 |
Legend Biotech
LEGN
|
$19.1M |
| 3 |
Trip.com Group
TCOM
|
$15.6M |
| 4 |
Zai Lab
ZLAB
|
$7.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$3.55M |
Sector Composition
| 1 | Consumer Discretionary | 36.1% |
| 2 | Technology | 29.22% |
| 3 | Communication Services | 14% |
| 4 | Healthcare | 8.72% |
| 5 | Real Estate | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Akero Therapeutics
AKRO
$3.58B
| $357K | 0.03% |
9,340
-264
| -3% | -$10.1K |
|
202
Acadia Pharmaceuticals
ACAD
$4.26B
| $355K | 0.03% |
18,867
-10,303
| -35% | -$194K |
|
203
Halozyme
HALO
$8.76B
| $354K | 0.03% |
9,277
+1,850
| +25% | +$70.6K |
|
204
Electronic Arts
EA
$42.2B
| $353K | 0.03% |
2,929
-214
| -7% | -$25.8K |
|
205
Kymera Therapeutics
KYMR
$3.11B
| $352K | 0.03% |
11,870
+578
| +5% | +$17.1K |
|
206
GlobalFoundries
GFS
$18.5B
| $350K | 0.03% |
4,855
-323
| -6% | -$23.3K |
|
207
Walt Disney
DIS
$212B
| $341K | 0.02% |
3,403
-126
| -4% | -$12.6K |
|
208
Syndax Pharmaceuticals
SNDX
$1.47B
| $339K | 0.02% |
16,065
+2,202
| +16% | +$46.5K |
|
209
Dollar Tree
DLTR
$20.6B
| $338K | 0.02% |
2,358
-160
| -6% | -$22.9K |
|
210
Denali Therapeutics
DNLI
$2.26B
| $337K | 0.02% |
14,619
-242
| -2% | -$5.58K |
|
211
Fastenal
FAST
$55.1B
| $332K | 0.02% |
12,298
-868
| -7% | -$23.4K |
|
212
Linde
LIN
$220B
| $326K | 0.02% |
918
-41
| -4% | -$14.6K |
|
213
MannKind Corp
MNKD
$1.7B
| $322K | 0.02% |
78,504
+11,303
| +17% | +$46.4K |
|
|
SWTX
214
DELISTED
SpringWorks Therapeutics
SWTX
| $320K | 0.02% |
12,422
-4,283
| -26% | -$110K |
|
215
Verisk Analytics
VRSK
$37.8B
| $320K | 0.02% |
1,670
-125
| -7% | -$24K |
|
216
Baker Hughes
BKR
$44.9B
| $314K | 0.02% |
10,880
-571
| -5% | -$16.5K |
|
217
Roivant Sciences
ROIV
$8.82B
| $313K | 0.02% |
42,346
+29,236
| +223% | +$216K |
|
|
WBA
218
DELISTED
Walgreens Boots Alliance
WBA
| $312K | 0.02% |
9,016
-622
| -6% | -$21.5K |
|
219
Keysight
KEYS
$28.9B
| $311K | 0.02% |
1,926
+128
| +7% | +$20.7K |
|
220
Verizon
VZ
$187B
| $304K | 0.02% |
7,823
-308
| -4% | -$12K |
|
221
Elevance Health
ELV
$70.6B
| $303K | 0.02% |
658
-8
| -1% | -$3.68K |
|
222
CoStar Group
CSGP
$37.9B
| $302K | 0.02% |
4,381
-262
| -6% | -$18.1K |
|
223
Dynavax Technologies
DVAX
$1.18B
| $301K | 0.02% |
30,717
-3,176
| -9% | -$31.1K |
|
224
Medtronic
MDT
$119B
| $301K | 0.02% |
3,735
-183
| -5% | -$14.7K |
|
225
Celldex Therapeutics
CLDX
$1.52B
| $298K | 0.02% |
8,271
+760
| +10% | +$27.4K |
|